Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-015778

President and CEO sold 450,000 shares at $2.87 ($1,291,500)

  • President and CEO acquired 315,450 shares (option exercise)
  • President and CEO gave up 5,343 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Culley Brian M · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-28 Exercise or conversion : show line 1 in the form +300,000 $0.69 $207,570 495,709 D
2021-06-28 Sale : show line 2 in the form −450,000 $2.87 $1,291,500 45,709 D
2021-06-30 Exercise or conversion : show line 3 in the form +15,450 $2.85 $44,033 61,159 D
2021-06-30 Shares withheld for taxes : show line 4 in the form −5,343 $2.85 $15,228 55,816 D
Open-market sales · 450,000 sh · avg $2.87 · $1,291,500

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-06-28 Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) −300,000 933,300 D
2021-06-30 Exercise or conversion : show line 6 in the form Restricted Stock Units −15,450 61,800 D
Loading xslF345X03/ownership.xml…